LifeMD, Inc (LFMD)

Etorro trading 970x250

About LifeMD, Inc

LifeMD, Inc. operates as a telemedicine company with a portfolio of online direct-to-consumer brands. The company combines virtual medical treatment with prescription medications and over-the-counter products. Its network of physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. Its brand portfolio comprises of brands targeting market segments, such as hair loss, immune health, men’s health, and disaster preparedness. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York. Address: 800 Third Avenue, New York, NY, United States, 10022

LifeMD, Inc News and around…

Latest news about LifeMD, Inc (LFMD) common stock and company :

LifeMD to Participate in the Stephens Annual Investment Conference
16 Nov, 2021 Yahoo! Finance

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) today announced that management will present at the Stephens Annual Investment Conference on Monday, November 29, 2021 and will host one-on-one meetings. Presentation details are as follows: Stephens Annual Investment Conference – Nashville 2021Date: Monday, November 29, 2021Time:9:00am CT / 10:00am ETWebcast Link:https://kvgo.com/stephens/lifemd-inc-2021 The presentation will be available for replay via the

Interesting LFMD Call Options For November 19th
15 Nov, 2021 FinancialContent

Investors in LifeMD Inc (LFMD) saw new options become available this week, for the November 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LFMD options chain for the new November 19th contracts and identified the following call contract of particular interest.

Could The LifeMD, Inc. (NASDAQ:LFMD) Ownership Structure Tell Us Something Useful?
15 Nov, 2021 Yahoo! Finance

A look at the shareholders of LifeMD, Inc. ( NASDAQ:LFMD ) can tell us which group is most powerful. Generally...

LifeMD Reports Q3 2021 Revenue Up 127% to Record $24.9 Million and 24% Sequential Improvement in Adjusted EBITDA
10 Nov, 2021 Yahoo! Finance

Revenue increased to a record $24.9 million, up 127% from the same year-ago period24% sequential improvement in Adjusted EBITDA versus prior quarter93% of Q3 2021 revenue generated by subscriptions, up from 61% in the same year-ago periodTotal telehealth order volume grew 153% to 232,293 NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the third quarter ended September 30, 2021. All figure comparisons ar

Interesting LFMD Put And Call Options For February 2022
09 Nov, 2021 FinancialContent

Investors in LifeMD Inc (LFMD) saw new options become available this week, for the February 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 101 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

LifeMD Launches Virtual Care Platform, Bringing Accessible, Affordable Healthcare to Patients Nationwide
08 Nov, 2021 Yahoo! Finance

Access to care 24/7 at affordable rates, a physician who knows you personally, unlimited messaging with dedicated medical team, and discounted prescription medicationsNEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the launch of its virtual care platform – a quantum leap in healthcare that uses telemedicine to connect patients directly with a doctor anytime, anywhere. The LifeMD virtual care platform combine

LifeMD to Present at the Credit Suisse Virtual Annual Healthcare Conference
02 Nov, 2021 Yahoo! Finance

NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company that offers cash-pay, virtual medical care across all 50 states through its network of affiliated providers, today announced that management will present at the Credit Suisse Virtual Annual Healthcare Conference taking place virtually on November 8-11, 2021. The company will present an overview on Thursday, November 11, 2021, at 10:30 am ET. Investors ma

LifeMD to Release Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
26 Oct, 2021 Yahoo! Finance

Hosted conference call to begin at 5:00 p.m. ETNEW YORK, Oct. 26, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescription medications and over the counter products to patients across all 50 states. The Company today announced that it will host a conference call to discuss its financial results for third quarter fiscal 2021, on Wednesday, November 10, 2021 after the

First Week of May 2022 Options Trading For LifeMD
25 Oct, 2021 FinancialContent

Investors in LifeMD Inc (LFMD) saw new options become available this week, for the May 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 207 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

35 Biggest Movers From Friday
11 Oct, 2021 FinancialContent

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s ...

LifeMD Announces Closing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulative Perpetual Preferred Stock
04 Oct, 2021 Yahoo! Finance

NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company today announced the closing of its previously announced underwritten registered public offering of 1,400,000 shares of its 8.875% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), with a total liquidation preference of $35,000,000. In connection with this offering, the Company has granted the und

LifeMD Announces Closing of Public Offering of Common Stock and Exercise of the Underwriters’ Option
04 Oct, 2021 Yahoo! Finance

NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the closing of its previously announced underwritten registered public offering of 3,833,334 shares of its common stock, par value $0.01 per share, which includes 500,000 shares of common stock issued upon the exercise in full of the underwriter’s option to purchase additional shares of common stock. The Company intends to use the net proceeds a

LifeMD Announces Pricing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulative Perpetual Preferred Stock
30 Sep, 2021 FinancialContent
LifeMD Announces Pricing of Public Offering of Common Stock
29 Sep, 2021 FinancialContent
LifeMD Announces Launch of Public Offering of Common Stock
28 Sep, 2021 FinancialContent
LifeMD Announces Launch of Public Offering of 1,400,000 Shares of Preferred Stock
28 Sep, 2021 FinancialContent
LifeMD to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
21 Sep, 2021 FinancialContent
Thursday 9/16 Insider Buying Report: LFMD, TUEM
16 Sep, 2021 FinancialContent

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

The Non-Independent Director of LifeMD, Inc. (NASDAQ:LFMD), Happy Walters, Just Bought 2.0% More Shares
16 Sep, 2021 Yahoo! Finance

Potential LifeMD, Inc. ( NASDAQ:LFMD ) shareholders may wish to note that the Non-Independent Director, Happy Walters...

LifeMD Appoints Seasoned Investor Naveen Bhatia to Board of Directors
13 Sep, 2021 FinancialContent

Industry veteran brings deep financial and management expertise to LifeMD as company continues to transform healthcare and build out growing telehealth platform

LifeMD to Present at the H.C. Wainwright Annual Global Investment Conference
08 Sep, 2021 FinancialContent
Grab This Bargain Even Cheaper Than Chief Business Officer Deutsch Did
02 Sep, 2021 FinancialContent

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 25, LifeMD Inc's Chief Business Officer, Corey Deutsch, invested $49,240.96 into 6,400 shares of LFMD, for a cost per share of $7.69..

Top Buys by Top Brass: Chief Business Officer Deutsch's $360K Bet on LFMD
31 Aug, 2021 FinancialContent

A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..

LifeMD Partners With Prescryptive Health, Expanding Convenience and Affordability for Patients
30 Aug, 2021 FinancialContent

Strategic partnership provides LifeMD with a vertically integrated, best-in-class pharmacy fulfillment and e-prescribing technology platform and immediate access to nationwide pharmacy network

78 Biggest Movers From Friday
16 Aug, 2021 FinancialContent

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported ...

53 Stocks Moving In Friday's Mid-Day Session
13 Aug, 2021 FinancialContent

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The ...

LifeMD Reports Q2 2021 Revenue Up 145% to Record $22.3 Million, Driven by Reduced Acquisition Costs and Strong Retention
12 Aug, 2021 FinancialContent
LifeMD is Now Oversold (LFMD)
11 Aug, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

LifeMD, Inc. Partners With Particle Health to Provide Comprehensive Health Records Offering a More Personalized Approach to Medical Care
04 Aug, 2021 FinancialContent
CCON's Holdings Imply 29% Gain Potential
29 Jul, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Direxion Connected Consumer ETF ETF (CCON), we found that the implied analyst target price for the ETF based upon its underlying holdings is $74.48 per unit.

LifeMD, Inc (LFMD) is a NASDAQ Common Stock listed in , ,

970x250